Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft

B N Becker1, L M Jacobson, D A Hullett

  • 1Department of Medicine, University of Wisconsin, Department of Veterans Affairs Hospital, Madison 53705, USA. bnb@medicine.wisc.edu

Clinical Nephrology
|February 12, 2002
PubMed
Abstract

Insights

The type 2 angiotensin II receptor (AT2R) is expressed in adult human renal transplants. Its expression correlates with genes involved in extracellular matrix regulation and chronic allograft nephropathy.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • The renin-angiotensin system (RAS) is implicated in renal fibrosis via the type I angiotensin II receptor (AT1R).
  • The role of the type 2 angiotensin II receptor (AT2R) in renal fibrosis in adult human tissue remains unclear.

Purpose of the Study:

  • To investigate the expression and role of AT2R in adult human renal allografts.
  • To determine if AT2R expression correlates with fibrotic processes and chronic rejection.

Main Methods:

  • Reverse-transcription polymerase chain reaction (RT-PCR) was used to measure AT2R mRNA in renal transplant biopsy samples.
  • Correlations between AT2R mRNA, matrix-modulating genes, and chronic rejection histology were assessed.

Main Results:

  • AT2R mRNA was detected and confirmed by sequence analysis.
  • AT2R mRNA expression positively correlated with angiotensinogen and matrix-modulating genes (TGF-beta, MMP-1, TIMP-2, TIMP-3).
  • AT2R mRNA and protein levels were higher in patients with chronic allograft nephropathy.

Conclusions:

  • AT2R mRNA is expressed in adult human renal transplants.
  • AT2R expression is associated with matrix-modulating genes, suggesting a role in extracellular matrix regulation.
  • These findings hypothesize a link between AT2R and the pathogenesis of chronic allograft nephropathy.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...